rs7540850

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000367573.7(CACNA1E):​c.1316-13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.703 in 1,610,998 control chromosomes in the GnomAD database, including 406,734 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 30270 hom., cov: 33)
Exomes 𝑓: 0.71 ( 376464 hom. )

Consequence

CACNA1E
ENST00000367573.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.190

Publications

8 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-181717080-T-C is Benign according to our data. Variant chr1-181717080-T-C is described in ClinVar as Benign. ClinVar VariationId is 1192683.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.748 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000367573.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1E
NM_001205293.3
MANE Select
c.1316-13T>C
intron
N/ANP_001192222.1
CACNA1E
NM_000721.4
c.1316-13T>C
intron
N/ANP_000712.2
CACNA1E
NM_001205294.2
c.1316-13T>C
intron
N/ANP_001192223.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1E
ENST00000367573.7
TSL:1 MANE Select
c.1316-13T>C
intron
N/AENSP00000356545.2
CACNA1E
ENST00000360108.7
TSL:5
c.1316-13T>C
intron
N/AENSP00000353222.3
CACNA1E
ENST00000367570.6
TSL:1
c.1316-13T>C
intron
N/AENSP00000356542.1

Frequencies

GnomAD3 genomes
AF:
0.599
AC:
91163
AN:
152078
Hom.:
30249
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.287
Gnomad AMI
AF:
0.711
Gnomad AMR
AF:
0.661
Gnomad ASJ
AF:
0.712
Gnomad EAS
AF:
0.767
Gnomad SAS
AF:
0.654
Gnomad FIN
AF:
0.760
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.727
Gnomad OTH
AF:
0.599
GnomAD2 exomes
AF:
0.681
AC:
169553
AN:
248938
AF XY:
0.688
show subpopulations
Gnomad AFR exome
AF:
0.276
Gnomad AMR exome
AF:
0.645
Gnomad ASJ exome
AF:
0.708
Gnomad EAS exome
AF:
0.754
Gnomad FIN exome
AF:
0.757
Gnomad NFE exome
AF:
0.726
Gnomad OTH exome
AF:
0.699
GnomAD4 exome
AF:
0.714
AC:
1041334
AN:
1458802
Hom.:
376464
Cov.:
33
AF XY:
0.713
AC XY:
517811
AN XY:
725946
show subpopulations
African (AFR)
AF:
0.272
AC:
9076
AN:
33414
American (AMR)
AF:
0.651
AC:
29128
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.711
AC:
18563
AN:
26106
East Asian (EAS)
AF:
0.788
AC:
31256
AN:
39686
South Asian (SAS)
AF:
0.652
AC:
56231
AN:
86204
European-Finnish (FIN)
AF:
0.756
AC:
40358
AN:
53384
Middle Eastern (MID)
AF:
0.614
AC:
3535
AN:
5754
European-Non Finnish (NFE)
AF:
0.731
AC:
811324
AN:
1109278
Other (OTH)
AF:
0.695
AC:
41863
AN:
60262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
16283
32566
48850
65133
81416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19888
39776
59664
79552
99440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.599
AC:
91215
AN:
152196
Hom.:
30270
Cov.:
33
AF XY:
0.605
AC XY:
45020
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.286
AC:
11897
AN:
41526
American (AMR)
AF:
0.661
AC:
10105
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.712
AC:
2468
AN:
3468
East Asian (EAS)
AF:
0.768
AC:
3972
AN:
5174
South Asian (SAS)
AF:
0.655
AC:
3159
AN:
4826
European-Finnish (FIN)
AF:
0.760
AC:
8055
AN:
10594
Middle Eastern (MID)
AF:
0.599
AC:
176
AN:
294
European-Non Finnish (NFE)
AF:
0.727
AC:
49465
AN:
68006
Other (OTH)
AF:
0.603
AC:
1270
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1629
3259
4888
6518
8147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.673
Hom.:
47976
Bravo
AF:
0.577
Asia WGS
AF:
0.667
AC:
2321
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Developmental and epileptic encephalopathy, 69 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.5
DANN
Benign
0.29
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7540850; hg19: chr1-181686216; COSMIC: COSV62386641; COSMIC: COSV62386641; API